与衰老相关的基因c-Myc通过与HSP90B1相互作用来影响膀癌细胞衰老,以调节西斯普拉丁敏感性
Yaxuan Wang1, Haixia Zhu2, Haifei Xu1
1Department of Urology, Affiliated Tumor Hospital of Nantong University and Nantong Tumor Hospital, Nantong 226361, China.
Aging
|July 11, 2023
概括
通过向c-Myc和HSP90B1来诱导细胞衰老,通过调节p21通路来增强膀癌细胞对西斯普拉丁化疗的敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 晚期膀癌通常会对化疗产生抵抗力,导致复发.
- 诱导细胞衰老是一种潜在的策略,可以改善固体瘤的短期药物敏感性.
研究的目的:
- 调查c-Myc在膀癌细胞衰老和思丁敏感性中的作用.
- 在膀癌中通过c-Myc/HSP90B1阐明p21的调节机制.
主要方法:
- 对c-Myc在膀癌预后和西斯普拉丁敏感性的生物信息分析.
- 细胞计数套件-8,克隆形成和与衰老相关的β-galactosidase试验,以评估细胞生长,衰老和思丁敏感性.
- 西部斑点和免疫沉分析c-Myc/HSP90B1/p21相互作用和信号通路.
主要成果:
- c-Myc与膀癌预后和西斯普拉丁敏感性有显著的相关性.
- 降低c-Myc抑制增殖,促进衰老,并增强了对西斯的敏感性.
- HSP90B1与c-Myc相互作用,其减少减轻了c-Myc诱导的作用,并改善了对西斯的敏感性.
结论:
- HSP90B1/c-Myc相互作用调节p21信号通路,影响膀癌细胞衰老和西斯普拉丁化学敏感性.
- 准HSP90B1/c-Myc轴提供了一种潜在的治疗策略,以克服膀癌中西斯普拉丁耐药性.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.7K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
